Literature DB >> 660211

Phenytoin dosage in ambulant epileptic patients.

C Terrence, M Alberts.   

Abstract

Ambulant patients with recently diagnosed generalised or psychomotor seizure disorders or both were randomly assigned to two dosage regimens of phenytoin. Drug compliance was evaluated with subsequent blood phenytoin levels four to eight weeks after initial enrollment into the study. Although the two groups had similar mg-kg daily dosages of phenytoin, the mean blood levels were statistically different between the two groups, favoring the simplified dosage regimen. Once or twice a day dosage regimens of phenytoin had a beneficial effect on drug compliance when compared to more frequent regimens as measured by phenytoin blood levels.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 660211      PMCID: PMC493056          DOI: 10.1136/jnnp.41.5.463

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Simultaneous gas-chromatographic analysis for phenobarbital, diphenylhydantoin, carbamazepine, and primidone in serum.

Authors:  C V Abraham; H D Joslin
Journal:  Clin Chem       Date:  1976-06       Impact factor: 8.327

2.  A study of the pharmacokinetics of phenytoin (diphenylhydantoin) in epileptic patients, and the development of a nomogram for making dose increments.

Authors:  A Richens
Journal:  Epilepsia       Date:  1975-11       Impact factor: 5.864

3.  Drug defaulting. I. Determinants of compliance.

Authors:  J R Boyd; T R Covington; W F Stanaszek; R T Coussons
Journal:  Am J Hosp Pharm       Date:  1974-04

4.  Effectiveness of single daily doses of diphenylhydantoin.

Authors:  A F Haerer; R A Buchanan
Journal:  Neurology       Date:  1972-10       Impact factor: 9.910

5.  Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients.

Authors:  A F Haerer; J B Grace
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

6.  Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care.

Authors:  A I Mushlin; F A Appel
Journal:  Arch Intern Med       Date:  1977-03

7.  Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures.

Authors:  L Lund
Journal:  Arch Neurol       Date:  1974-11

8.  Some causes of ineffectiveness of diphenylhydantoin.

Authors:  H Kutt; J Haynes; F McDowell
Journal:  Arch Neurol       Date:  1966-05

9.  SERUM DIPHENYLHYDANTOIN (PHENYTOIN) IN AMBULANT PATIENTS WITH EPILEPSY.

Authors:  M LUND; R S JORGENSEN; V KUEHL
Journal:  Epilepsia       Date:  1964-03       Impact factor: 5.864

10.  The metabolism of diphenylhydantoin (Dilantin) following once-daily administration.

Authors:  R A Buchanan; A W Kinkel; J R Goulet; T C Smith
Journal:  Neurology       Date:  1972-02       Impact factor: 9.910

View more
  1 in total

1.  Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis.

Authors:  J K McQueen; D H Blackwood; P Harris; R M Kalbag; A L Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.